PETROS PHARMACEUTICALS INC shareholders Q2 2023

PETROS PHARMACEUTICALS INC's ticker is and the CUSIP is 71678J209. A total of 15 filers reported holding PETROS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

PETROS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
EMFO, LLC 1,000$2,0300.00%
Newbridge Financial Services Group, Inc. 120$2440.00%
Renaissance Technologies 16,779$340.00%
VANGUARD GROUP INC 31,811$64,5760.00%
Schonfeld Strategic Advisors LLC 23,200$47,0960.00%
OSAIC HOLDINGS, INC. 14$280.00%
BANK OF AMERICA CORP /DE/ 14$280.00%
FIRST MANHATTAN CO. LLC. 10$200.00%
WELLS FARGO & COMPANY/MN 11$220.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 79$1600.00%
MORGAN STANLEY 19$390.00%
BANK OF MONTREAL /CAN/ 10,000$27,4000.00%
BlackRock Inc. 16,510$33,5150.00%
Tower Research Capital LLC (TRC) 2,546$5,1680.00%

This page lists PETROS PHARMACEUTICALS INC's shareholders in Q2 2023. To view PETROS PHARMACEUTICALS INC's shareholder history, click here.